Gene · 9055
Papers4,169
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,169
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of key genes participating in copper-diethyldithiocarbamate-related cell death process and predicting the development of prostate cancer. | Discov Oncol | 2024 | 39361158 | PubTator, text mining | PubMed |
| Artificial intelligence and bioinformatics: a journey from traditional techniques to smart approaches. | Gastroenterol Hepatol Bed Bench | 2024 | 39308539 | PubTator, text mining | PubMed |
| Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer. | Cancers (Basel) | 2024 | 39272883 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch. | Sci Adv | 2024 | 39196936 | PubTator, text mining | PubMed |
| A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma. | NAR Genom Bioinform | 2024 | 39184376 | PubTator, text mining | PubMed |
| Editorial: Fertilization and early development: genetics and epigenetics. | Front Genet | 2024 | 39139820 | PubTator, text mining | PubMed |
| Ase1 selectively increases the lifetime of antiparallel microtubule overlaps. | Curr Biol | 2024 | 39137787 | PubTator, text mining | PubMed |
| Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. | Med Oncol | 2024 | 39115587 | PubTator, text mining | PubMed |
| H3K27me3-mediated epigenetic regulation in pluripotency maintenance and lineage differentiation. | Cell Insight | 2024 | 39072246 | PubTator, text mining | PubMed |
| Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. | NPJ Precis Oncol | 2024 | 39054369 | PubTator, text mining | PubMed |
| GAS6-AS1 drives bladder cancer progression by increasing MMP7 expression in a ceRNA- and RBP-dependent manner. | Transl Oncol | 2024 | 39053343 | PubTator, text mining | PubMed |
| Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism. | EBioMedicine | 2024 | 39002386 | PubTator, text mining | PubMed |
| EZH2-associated tumor malignancy: A prominent target for cancer treatment. | Clin Genet | 2024 | 38881299 | PubTator, text mining | PubMed |
| Heterogeneous distribution of kinesin-streptavidin complexes revealed by mass photometry. | Soft Matter | 2024 | 38832814 | PubTator, text mining | PubMed |
| CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression. | Cell Death Dis | 2024 | 38816356 | PubTator, text mining | PubMed |
| Irbesartan ameliorates diabetic kidney injury in db/db mice by restoring circadian rhythm and cell cycle. | J Transl Int Med | 2024 | 38799791 | PubTator, text mining | PubMed |
| Variant PRC1 subunit RYBP/YAF2 forms condensate with RING1B and promotes H2AK119ub deposition. | Sci China Life Sci | 2024 | 38739171 | PubTator, text mining | PubMed |
| LncRNAs, nuclear architecture and the immune response. | Nucleus | 2024 | 38738760 | PubTator, text mining | PubMed |
| Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach. | In Silico Pharmacol | 2024 | 38721057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9055/papers?page=10